Cargando…

Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open‐label trial

OBJECTIVE: To evaluate the pharmacokinetics, safety, and tolerability of brivaracetam (BRV) as 15‐min intravenous (IV) infusion and bolus (≤2‐min injection). METHODS: EP0065 (ClinicalTrials.gov: NCT03405714) was a Phase 2, multicenter, open‐label trial in patients ≥1 month to <16 years of age wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farkas, Mark Kristof, Kang, Harriet, Fogarasi, Andras, Bozorg, Ali, James, Gareth D., Krauwinkel, Walter, Morita, Diego, Will, Edgar, Elshoff, Jan‐Peer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303197/ https://www.ncbi.nlm.nih.gov/pubmed/35196395 http://dx.doi.org/10.1111/epi.17187

Ejemplares similares

Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design
por: Bast, Thomas, et al.
Publicado: (2022)

Safety and tolerability of short‐term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open‐label, phase 2/3 trial
por: Farkas, Mark Kristof, et al.
Publicado: (2023)

Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial
por: Liu, Edwin, et al.
Publicado: (2019)

Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years
por: Schoemaker, Rik, et al.
Publicado: (2017)

Profile of brivaracetam and its potential in the treatment of epilepsy
por: Ferlazzo, Edoardo, et al.
Publicado: (2015)

Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences
por: Zahnert, Felix, et al.
Publicado: (2018)

Emerging drugs for partial-onset epilepsy: a review of brivaracetam
por: Gao, Lan, et al.
Publicado: (2016)

New developments in the management of partial-onset epilepsy: role of brivaracetam
por: Coppola, Giangennaro, et al.
Publicado: (2017)

Brivaracetam in the treatment of epilepsy: a review of clinical trial data
por: Feyissa, Anteneh M
Publicado: (2019)

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study
por: Maschio, Marta, et al.
Publicado: (2020)

Pharmacokinetics, Safety and Tolerability of Rotigotine Transdermal Patch in Healthy Japanese and Caucasian Subjects
por: Cawello, Willi, et al.
Publicado: (2013)

Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
por: Abraira, L., et al.
Publicado: (2021)

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Intravenous Brivaracetam in the Management of Acute Seizures in the Hospital Setting: A Scoping Review
por: Lee, Kiwon, et al.
Publicado: (2022)

Α Multicenter Retrospective Study Evaluating Brivaracetam in the Treatment of Epilepsies in Clinical Practice
por: Stefanatou, Maria, et al.
Publicado: (2021)

Clinical and Electroencephalography Assessment of the Effects of Brivaracetam in the Treatment of Drug-Resistant Focal Epilepsy
por: Savastano, Ersilia, et al.
Publicado: (2021)

Safety and efficacy of brivaracetam in children epilepsy: a systematic review and meta-analysis
por: Song, Ting, et al.
Publicado: (2023)

Acute and long‐term effects of brivaracetam and brivaracetam–diazepam combinations in an experimental model of status epilepticus
por: Niquet, Jerome, et al.
Publicado: (2017)

Clinical and Economic Outcomes of Intravenous Brivaracetam Compared With Levetiracetam for the Treatment of Seizures in United States Hospitals
por: Beaty, Silky, et al.
Publicado: (2021)

Brivaracetam substituting other antiepileptic treatments: Results of a retrospective study in German epilepsy centers
por: Lerche, Holger, et al.
Publicado: (2020)

First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study
por: Menzler, Katja, et al.
Publicado: (2019)

Brivaracetam in treating epileptic encephalopathy and refractory focal epilepsies in patients under 14 years of age
por: RUSSO, Angelo, et al.
Publicado: (2021)

A review of the pharmacology and clinical efficacy of brivaracetam
por: Klein, Pavel, et al.
Publicado: (2018)

Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2022)

Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy
por: Vuu, Irene, et al.
Publicado: (2016)

An Update on Pharmacological, Pharmacokinetic Properties and Drug–Drug Interactions of Rotigotine Transdermal System in Parkinson’s Disease and Restless Legs Syndrome
por: Elshoff, Jan-Peer, et al.
Publicado: (2015)

Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany
por: Willems, Laurent M., et al.
Publicado: (2018)

Childhood Absence Epilepsy Successfully Treated with the Paleolithic Ketogenic Diet
por: Clemens, Zsófia, et al.
Publicado: (2013)

Synthetic Approaches toward the Synthesis of Brivaracetam: An Antiepileptic Drug
por: Gayke, Manoj, et al.
Publicado: (2022)

Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial
por: O’Brien, Terence J., et al.
Publicado: (2020)

Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
por: Villanueva, Vicente, et al.
Publicado: (2023)

Steady-state Carbamazepine Pharmacokinetics following Oral and Stable-Labeled Intravenous Administration in Epilepsy Patients: Effect of Race and Sex
por: Marino, SE, et al.
Publicado: (2012)

Brivaracetam: a novel antiepileptic drug for focal-onset seizures
por: Stephen, Linda J., et al.
Publicado: (2017)

In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells
por: Rizzo, Ambra, et al.
Publicado: (2017)

Time course of 75%–100% efficacy response of adjunctive brivaracetam
por: Klein, Pavel, et al.
Publicado: (2020)

Rise of the Machines? Predicting Brivaracetam Response Using Machine Learning
por: Terman, Samuel W.
Publicado: (2021)

Synthesis of the Brivaracetam Employing Asymmetric Photocatalysis and Continuous Flow Conditions
por: Franco, Marcelo S., et al.
Publicado: (2023)

Pharmacokinetics and tolerability of lefamulin following intravenous and oral dosing
por: Wicha, Wolfgang W, et al.
Publicado: (2019)

Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants
por: Pfiffner, Miriam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4o1becbk12sg0gjcfa0qpd20b4